Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
dihydroergotamine
3
×
life sciences
national blog main
new york blog main
new york top stories
3
×
san francisco blog main
san francisco top stories
satsuma pharmaceuticals
bausch health
deals
generic drugs
glaxosmithkline
medical device
migraine
multiple myeloma
nirogacestat
raleigh-durham blog main
raleigh-durham top stories
springworks therapeutics
startups
10x genomics
abbvie
acute migrane
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bain capital
biogen
biotech ipos
boston blog main
boston top stories
boston university
boulder/denver blog main
What
companies
biotech
drug
ipo
satsuma
springworks
activity
approval
bio
biogen’s
biopharmaceutical
boost
convo
days
dog
earlier
failures
firm
followed
genomics
hasn’t
haul
ipos
leading
led
life
line
littered
markets
migraine
nash
new
news
pfizer
place
prep
price
public
remains
road
Language
unset
Current search:
dihydroergotamine
×
" new york top stories "
×
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More